Abstract
Introduction

Thyrotropin (TSH) mediates its function through highly specific interactions with the thyrotropin receptor (TSHR) [1]. In many autoimmune thyroid disorders, such as Graves' disease (GD), TSHR is a target of autoimmune antibodies, leading to dysfunction of the thyroid gland [2]. Several studies have demonstrated that TSHR expression is not confined to thyrocyte but can be detected in a number of non-thyroidal cells, such as lymphocytes
, adipocytes [4] , retroocular fibroblasts [5] , erythrocytes [6] , osteocytes [7] , neuronal cells and astrocytes [8] . Although the role of TSHR in these non-thyroid tissues is unclear, its expression and activity in these non-thyroid tissues may have physiopathological relevance [9] .
Recently, two separate studies reported that the level of hepatic production of C-reactive protein directly correlated with TSH levels in subclinical hypothyroidism patients [10, 11] [4, 12] . Agretti et al. [13] successfully detected TSHR mRNA in liver tissues of patients with non-thyroidal diseases. However, because of the very low levels of TSHR mRNA transcript, the authors speculated that this likely represented illegitimate transcription, which was defined as low transcription of a tissue-specific gene in nonspecific cells [14] . In 
, which indicated a potential association between TSH and hepatocytes. To date, the existence of TSHR in hepatocytes is a contentious issue. Previous studies have selected liver tissues as negative controls when detecting TSHR expression in chicken and rats
Materials and methods
Cell culture and sample collection
The normal human hepatocyte cell line L-02 was purchased from the Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China. L-02 cells were cultured as described previously [15] . Fig.1 A and B) . Similarly, a band of 169 bp was clearly detectable in the liver tissues of two rat species, consistent with that from the positive control, FRTL-5 cells (Fig.1 B) . Fig.2 A and B) . In addition, both of these sequences were identical to the published mRNA sequence of human TSHR derived from thyroid tissue.
RT-PCR and sequencing
Specificity confirmed by sequence
To validate the specificity of the amplified fragment, PCR products of TSHR from L-02 cells, human liver and thyroid samples were purified and sequenced in both directions. The results demonstrated that the TSHR sequences of L-02 cells and human liver tissue were identical (
Presence of TSHR protein in hepatocytes
Immunoprecipitation of TSHR was performed to assess TSHR protein expression in hepatocytes. As seen in Figure 3 , a protein band of approximately 62 kD was detected in the positive controls. (Fig. 4B1) . (Fig. 5A) . Figure 5B , GD IgGs (100 g/ml) significantly increased cAMP production compared with control or cells treated with normal IgGs (both P Ͻ 0.05). We did not find any difference in cAMP production between the control and normal IgGs-treated cells.
Importantly, bands of the same size were detected in human liver tissues, L-02 cells and rat liver tissues. To examine the cellular distribution of TSHR protein in hepatocytes, immunofluorescent microscopy was performed on L-02 cells. As shown in Figure 4A1, immunoreactivity for the TSHR protein was clearly observed (green). As expected, the green fluorescence was present in the cell membrane. In contrast, the negative control (represented by the L-02 cells processed in the absence of the primary antibodies) showed no staining
Both bTSH and GD IgGs stimulated cAMP production in L-02 cells
To determine whether the TSHR protein observed in hepatocytes was functional, we investigated the effect of bTSH stimulation on cAMP production. Compared with the control, bTSH significantly increased the cAMP levels by 114% at 2 M bTSH (P Ͻ 0.05) and by 179% at 4 M bTSH (P Ͻ 0.01). In addition, high (4 M) concentrations of bTSH stimulated a two-fold increase in cAMP production relative to low (0.2 M) concentrations (P Ͻ 0.01), indicating that bTSH increases cAMP production in hepatocytes in a dose-dependent manner
The production of cAMP in L-02 cells was also assayed after incubation with GD IgGs or normal IgGs. As shown in
Discussion
The evidence presented in this paper demonstrates that both TSHR mRNA and protein were present in human and rat liver tissues, as well as in the cultured normal human hepatocyte cell line L-02. Furthermore, the TSHR in hepatocytes is functional, as [19] . Measurement of cAMP concentrations after TSH treatment is also commonly used to determine functional TSHR in non-thyroid cells, such as fibroblasts and adipocytes [20, 21] . In this study, we clearly demonstrated that bTSH-stimulated cAMP production in a dose-dependent fashion, indicating that the TSHR protein expressed in hepatocytes is functional. To our knowledge, this is the first evidence that hepatocytes possess a functional TSHR. It should be noted that the bTSH concentrations (0.2-4 M) used in the present study were higher than that in normal people or patients with hypothyroidism, similar to the concentrations used for thyrocytes in culture [22] or for non-thyrocytes in culture, such as 3T3-L1 preadipocytes [23] and fibroblasts [20] . The reason for the need for a lower concentration of TSH in human body is possibly the synergistic action of coexisting growth factors/cytokines such as IGF-1 to augment TSH signaling in vivo [22] . Of greater interest is the result that GD IgGs from TRAb positive sera also stimulated cAMP production in hepatocytes, whereas normal IgGs did not show the same effect, similar to that reported in fibroblasts [20] .
Albeit [2] . Although there are many clinical and laboratory associations between thyroid and liver diseases [24] , previous studies have only focused on the relationship between thyroid hormones and the liver [24] . There are many unexplained metabolic derangements in endocrine conditions associated with abnormal TSH. For example, Christ-Crain et al. [10] and Tuzcu et al. [11] independently reported the elevation of hepatic C-reactive protein [25] 
